Associate Director, Epidemiology Oncology

Would you like to be part of GSK’s Epidemiology Department, with an opportunity to drive Epidemiology strategy and studies across the spectrum of drug development?  If so, this is an excellent opportunity to explore.

Job Purpose

As an Associate Director in Epidemiology, you will provide scientific leadership in the application of epidemiological expertise and methods to answer key challenges identified across all phases of drug development for an asset or disease area to deliver new drugs more efficiently and effectively to patients.

This position functions within the Epidemiology Department, which contributes to the successful development of new therapies. Our staff in Epidemiology provide leadership and expertise to develop and execute the Epidemiology strategy across the entire spectrum of drug development, from early discovery to registration and lifecycle management.

Key Responsibilities

This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following:

• Develops a network to ensure alignment of an epidemiology program with the broader asset/disease strategy and plays a role in developing a key understand across stakeholders of the impact of epidemiology on the asset/disease strategy. 
• Identifies new vendors, tools and data sources to deliver epidemiology solutions for the asset/disease area.
• Contributes to strategic initiatives on role of Epidemiology at departmental level.
• Accountable for program of epidemiology for an asset or disease area. 
• Brings RWE insights to inform asset/disease area strategy, development activities for one asset or disease area.
• Proposes and negotiates content of epidemiologic program and budget with matrix leader.
• Provides expert epidemiological consultation to asset matrix teams (Clinical Development Team, Safety Review Team, Integrated Evidence Team, Medicine Development Team).
• May contribute to advancing the science through membership of external initiatives (e.g. ICPE, IMI).
• May contribute to departmental initiatives driving innovative solutions through evaluation of tools, methodologies or processes.

Why you?

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:

• Doctoral degree (PhD., ScD or DrPH) in epidemiology or other Quantitative Health discipline
• Experience applying epidemiologic methods in at least one disease area
• Experience operating in a matrix environment with independent delivery of increasingly complex epidemiological studies including regulatory requirements. 

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

• Demonstrated epidemiological expertise and developing the ability to influence key internal (matrix leaders) and external (regulators) stakeholders specifically around scientifically robust and strategic approaches to delivering epidemiological science to answer key asset challenges.
• Highly proficient written, verbal and listening skills. 
• Expertise in complex research techniques, tools, and procedures (e.g. quantitative research methods, multiple study designs).
• Experience in the pharmaceutical industry or equivalent experience in an academic or government setting
• Expertise in design, conduct and appropriate dissemination of de novo and epidemiologic database studies.
• Broad knowledge of private and public use datasets

Please visit  GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).

Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and chal